European Commission grants approval for cladribine

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

European Commission grants approval for cladribine

Post by MSUK » Tue Aug 29, 2017 4:04 am

The European Commission has approved Mavenclad, more commonly known as cladribine, for the treatment of highly active relapsing remitting multiple sclerosis (RRMS) patients across Europe...Read more - http://www.ms-uk.org/european-commissio ... cladribine
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post